We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gene Panel May Be Able to Identify Existing and Potential Alcoholics

By LabMedica International staff writers
Posted on 02 Jun 2014
A Convergent Functional Genomics (CFG) approach was used to discover genes involved in alcoholism in a study that has implications for genetic testing to assess risk for developing an illness before the illness manifests itself clinically.

The CFG technique was developed by Dr. More...
Alexander Niculescu of the Indiana University School of Medicine (Indianapolis, USA), and collaborators starting in 1999. It is an approach for identifying and prioritizing candidate genes and biomarkers for complex psychiatric and medical disorders by integrating and tabulating multiple lines of evidence including gene expression and genetic data from human studies and from animal model work. CFG generates a signal that is predictive and is reproducible in independent studies, as opposed to the fit-to-cohort aspect of classic human genetic studies like the genome-wide association study (GWAS), where the issue of genetic heterogeneity makes the top statistically significant findings from even large size studies less reproducible in independent studies.

In the current work, Dr. Niculescu and collaborators in the United States and Germany used CFG to analyze data from a German genome-wide study of alcoholism and data from a variety of other studies into genetic links to alcoholism. The analysis produced a group of 135 candidate genes. They then used a stress-reactive animal model of alcoholism, the D-box binding protein (DBP) knockout mouse, to identify genes expressed by both the alcoholic humans and the stress-reactive alcoholic mice.

This process yielded a panel of 11 genes with 66 single-nucleotide polymorphisms (SNPs). The investigators found that this panel of 11 genes could be used to differentiate between alcoholics and non-alcoholics in three different research populations for which genetic data and information about alcohol consumption were available: a group of Caucasian subjects and a group of African American subjects from the USA, and a third group from Germany.

"This powerful panel of just 11 genes successfully identified who has problems with alcohol abuse and who does not in tests in three patient populations on two continents, in two ethnicities and in both genders," said senior author Dr. Alexander B. Niculescu, associate professor of psychiatry and medical neuroscience at the Indiana University School of Medicine. "We believe this is the strongest result to date in the field of alcoholism and offers a comprehensive—though not exhaustive—window to the genetics and biology of alcoholism."

The study was published in the May 20, 2014, issue of the journal Translational Psychiatry.

Related Links:

Indiana University School of Medicine



New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.